News for Codiak BioSciences, Inc. (CDAK)

Operator: Good morning and good evening, ladies and gentlemen. Thank you for joining, and welcome to Chindata Group Holdings Limited Second Quarter 2023 Earnings Conference Call.

This is a summary of a request from Codiak BioSciences Inc. to hire Young Conaway Stargatt & Taylor LLP as counsel, filed April 7 with the U.S. Bankruptcy Court in Wilmington, Del.

Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | March 29, 2023

Shares of Codiak BioSciences Inc. plummeted 50.3% in premarket trading Monday after the Massachusetts-based biopharmaceutical company said it field for...

Operator: Good morning, and good evening, ladies and gentlemen. Thank you for joining, and welcome to Chindata Group Holdings Limited Fourth Quarter and Full Year 2022 Earnings Conference Call.

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the...

Codiak BioSciences, Inc. (CDAK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CAMBRIDGE, Mass., Sept. 20, 2022 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of Phillip... | September 20, 2022

Read Insider Buying: Codiak BioSciences, Inc. (NASDAQ:CDAK) Major Shareholder Buys 5,000,000 Shares of Stock at ETF Daily News

/PRNewswire/ -- The "Global Acellular Therapy Market - Strategies and Applications: Focus on Application, Pipeline, and Competitive Landscape" report has been...

Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of company-specific...

CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK) ("Codiak"), a clinical-stage biopharmaceutical company focused on ...

CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical compa...

CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) ("Codiak"), a clinical-stage biopharmaceutical company focused on

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 ...

CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK) ("Codiak"), a clinical-stage company focused on pioneering the ...